Akoya Biosciences Inc. is a life sciences technology company specializing in spatial biology solutions that enable researchers to study complex biological systems with high-resolution spatial information. The company was founded in 2015 by Brian McKelligon and Scott Manalis, with the aim of providing advanced tools for understanding the spatial organization of cells and molecules within tissues.
Based in Marlborough, Massachusetts, Akoya Biosciences developed the CODEX (CO-Detection by indEXing) platform, which allows researchers to analyze multiple biomarkers within tissue samples simultaneously. This technology enables a deeper understanding of cellular interactions and heterogeneity within tissues, supporting various applications such as cancer research, immunology, and drug discovery.
Akoya Biosciences' platform helps researchers gain insights into disease mechanisms and therapeutic responses by visualizing the distribution of specific biomarkers within tissue samples. The company's technology has the potential to accelerate the development of personalized medicine and targeted therapies.
In addition to its CODEX platform, Akoya Biosciences offers a range of solutions and services, including reagents, instruments, and software tools that enable researchers to analyze complex biological samples with high precision. As the field of spatial biology continues to grow, Akoya Biosciences remains at the forefront of providing innovative technologies that contribute to advancements in biomedical research and healthcare.